L-Carnitine Market Size, Share & Trends Report

L-Carnitine Market Size, Share & Trends Analysis Report By Process (Bioprocess, Chemical Synthesis), By Product (Food & Pharmaceutical Grade, Feed Grade), By Application, By Region, And Segment Forecasts, 2019 - 2025

  • Published Date: Oct, 2019
  • Base Year for Estimate: 2018
  • Report ID: GVR-3-68038-800-8
  • Format: Electronic (PDF)
  • Historical Data: 2014 - 2017
  • Number of Pages: 125

Industry Insights

The global L-carnitine market size was estimated at USD 168.2 million in 2018 and is expected to exhibit a CAGR of 4.8% over the forecast period. Growing health concerns among the geriatric population along with increasing consumer inclination toward preventive healthcare, is expected to drive industry growth over the forecast period.

L-carnitine is known to enhance post-exercise recovery among the elderly. It also helps in reducing fatigue and boosting mental functioning. Moreover, it minimizes the risk of skeletal decline, which is common among the aging population. The product is beneficial in maintaining lean muscle mass, reducing muscle degradation, and promoting healthy aging.

U.S. L-carnitine market

The product is also used for supplementing individuals with low levels of natural L-carnitine. Deficiency may occur due to various factors such as genetic disorders, consumption of certain drugs, and medical conditions such as skeletal myopathies. Such factors have exclusively bolstered demand for L-carnitine as dietary supplements.

Furthermore, increasing concerns regarding the quality and safety of meat have promoted the use of supplements in animal feed. The use of L-carnitine as a supplement in animal feed is likely to provide various benefits including growth performance and improved reproduction process. It is used in the feed of different domestic animals such as cows, pigeons, racing horses, and pigs to enhance their average gain rate and daily performance and growth. Expansion of the animal feed industry is likely to increase the demand for L-carnitine over the forecast period.

Technological advancements related to manufacturing techniques are projected to play a significant role in driving market growth. Complexity in the manufacturing process and misleading advertisements promoting hyped product benefits are expected to hamper market growth. The industry is also expected to face regulatory limitations due to the excessive amount of waste and wastewater created through the manufacturing processes.

Process Insights

The L-carnitine market is expected to witness significant growth over the forecast period owing to increasing innovations in manufacturing processes. Chemical synthesis and bioprocess are the commonly used processes for manufacturing. Bioprocess accounted for a significant market share in 2018 and is expected to continue the trend over the forecast period, owing to the highest yield and environmental benefits it offers. However, chemical synthesis is slowly gaining momentum in the market.

Chemical multistep racemization is the most commonly used chemical synthesis process for the manufacturing of L-carnitine, which generates racemic mixture with D-carnitine as a byproduct. The process generally starts with the inclusion of raw materials such as epichlorohydrin and trimethylamine, which is followed by separation of a racemic mixture by fractioned crystallization.

Rising commercial product demand has compelled manufacturers to improve their production processes to obtain improved yield. Biological processes using microorganisms and enzymes are inherently asymmetric processes. The most common bioprocess used for the production of L-carnitine with the highest yield is based on biotransformation of achiral precursors such as 3-dehydrocarnitine, crotonobetaine, and γ-butyrobetaine or racemic mixtures such as D, L-carnitine, D, L-acyl carnitine, and D, L-carnitinamide.

Product Insights

The industry is expected to witness substantial growth over the forecast period, owing to the rising consumer awareness regarding the benefits of L-carnitine supplementation. The feed and pharmaceutical grade segment accounted for the largest market share in 2018 and is expected to experience significant growth over the forecast period.

Moreover, increasing use of L-carnitine and its derivatives for animal feed is estimated to propel market growth over the forecast period. Food and pharmaceutical grade of the product is primarily used for human consumption for numerous applications including post-exercise recovery, weight management, infant nutrition, male fertility, and healthy aging.

Feed grade is widely used as a key ingredient in animal feed and animal pharmaceuticals. It is an essential component for energy metabolism in animals and offers a wide range of benefits to various species including weight management and healthy function of heart and liver. It is also primarily used as a supplement for pets with heart disease, especially dilated cardiomyopathy in dogs. Moreover, it is used as an essential supplement for the treatment of obesity, hyperlipidemia, and diabetic ketoacidosis, which are conditions commonly found in cats and dogs. The product is preferred for the treatment of fatty liver syndrome in cats.

Application Insights

L-carnitine and its derivatives witnessed substantial demand in 2018 and the trend is expected to continue over the forecast period. Healthcare products such as nutritional supplements for weight management, energy, and endurance accounted for the largest market share in 2018. This segment is expected to grow at a significant pace over the forecast period. However, the functional drinks segment is expected to witness the fastest CAGR of 6.1% in the foreseeable future.

In case of cows, L-carnitine supplements are used to increase their rate of lactation. In addition, oral administration of L-carnitine is advised for growing sheep to elevate plasm glucose concentrations. However, consistent consumption of L-carnitine supplements has proven to have positive effects on growth performance, carcass composition, and breeding performance of pigs.

Global L-Carnitine market

Altering the eating habits of the elderly population often leads to low appetite and decline in their energy levels. The decline in consumption of nutritious food results in reduced dietary intake of both L-carnitine and nutrients required to make L-carnitine. This reduction in energy metabolism due to low levels of L-carnitine can be restored with L-carnitine supplementation.

Regional Insights

The pharmaceutical sector in North America is the largest continental pharma market across the globe. The U.S. alone accounts for over 45% of the global pharmaceutical industry in terms of sales revenue owing to the presence of top global companies in the country.

Besides this, factors such as rising number of diseases and growth in research and development activities in the pharmaceutical industry are expected to impel regional growth. In addition, increase in spending power of the population in the U.S., Canada, and Mexico are expected to promote the growth of the pharmaceutical industry in North America. The use of L-carnitine in the pharmaceutical industry is expected to witness significant growth due to its multiple benefits in treating various disorders like kidney diseases, thyroid, and diabetes.

The U.S. exhibits a high prevalence of obesity and related health issues. L-carnitine helps in weight management, which is the primary factor leading to obesity. The product also helps in controlling obesity-related disorders such as diabetes, high blood pressure, heart diseases, and stroke.

L-Carnitine Market Share Insights

Market players are focused on providing vast product portfolio, better customer service, and enhanced value to their customers In addition, they are offering standalone or integrated and cost-effective solutions to assist organizations. They put high emphasis on providing customized products to their clients to gain a competitive edge. Moreover, these companies ensure to equip their facilities with high technical expertise and operational capacity to offer integrated services to their clients.

Key players operating in the market include Lonza Group Ltd., Northeast Pharmaceutical Group Co., Ltd. (NEPG), Biosint S.p.A., Cayman Chemical, Merck KGaA, Tokyo Chemical Industry Co., Ltd., Ceva Santé Animale S.A., Kaiyuan Hengtai Chemical Co., Ltd., Chengda Pharmaceuticals Co. Ltd., Huanggang Huayang Pharmaceutical Co. Ltd., and Hubei Yuancheng Technology Co. Ltd.

Report Scope

Attribute

Details

Base year for estimation

2018

Actual estimates/Historical data

2014 - 2017

Forecast period

2019 - 2025

Market representation

Volume in Tons, Revenue in USD Million, and CAGR from 2019 to 2025

Regional scope

North America, Europe, Asia Pacific, Central & South America, Middle East & Africa

Country scope

U.S., Canada, Mexico, Germany, U.K., France, Italy, China, India, Japan, South Korea, Brazil, Argentina, South Africa, Saudi Arabia

Report coverage

Volume forecast, revenue forecast, competitive landscape, growth factors and trends

15% free customization scope (equivalent to 5 analysts working days)

If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization


Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global L-carnitine market report on the basis of process, product, application, and region:

  • Process Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)

    • Chemical Synthesis

    • Bioprocess

  • Product Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)

    • Food & Pharmaceutical Grade

    • Feed Grade

  • Application Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)

    • Animal Feed

    • Healthcare Products

    • Functional Drinks

    • Medicines

  • Regional Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)

    • North America

      • U.S.

      • Canada

      • Mexico

    • Europe

      • Germany

      • U.K.

      • France

      • Italy

    • Asia Pacific

      • China

      • India

      • Japan

      • South Korea

    • Central & South America

      • Brazil

      • Argentina

    • Middle East & Africa

      • South Africa

      • Saudi Arabia

Key questions answered by the report
Request for Customization

Choose License Type

Single User - $5,950
Multi User (2-5) - $6,950
Enterprise Access - $8,950

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert.

  • Custom research service

    Custom research service

    Design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • grand view research PCI DSS complaint grand view research paypal verified